These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10791547)

  • 1. Dopamine-transporter density in patients with ADHD.
    Baughman FA
    Lancet; 2000 Apr; 355(9213):1460-1; author reply 1461-2. PubMed ID: 10791547
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine-transporter density in patients with ADHD.
    Swanson JM
    Lancet; 2000 Apr; 355(9213):1461; author reply 1461-2. PubMed ID: 10791548
    [No Abstract]   [Full Text] [Related]  

  • 3. The early development of child psychopharmacogenetics.
    Cook EH
    J Am Acad Child Adolesc Psychiatry; 1999 Dec; 38(12):1478-81. PubMed ID: 10596246
    [No Abstract]   [Full Text] [Related]  

  • 4. Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD).
    Vles JS; Feron FJ; Hendriksen JG; Jolles J; van Kroonenburgh MJ; Weber WE
    Neuropediatrics; 2003 Apr; 34(2):77-80. PubMed ID: 12776228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated striatal dopamine transporter in a drug naive patient with Tourette syndrome and attention deficit/ hyperactivity disorder: positive effect of methylphenidate.
    Krause KH; Dresel S; Krause J; Kung HF; Tatsch K; Lochmüller H
    J Neurol; 2002 Aug; 249(8):1116-8. PubMed ID: 12420715
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopamine transporter density in patients with attention deficit hyperactivity disorder.
    Dougherty DD; Bonab AA; Spencer TJ; Rauch SL; Madras BK; Fischman AJ
    Lancet; 1999 Dec 18-25; 354(9196):2132-3. PubMed ID: 10609822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder.
    van Dyck CH; Quinlan DM; Cretella LM; Staley JK; Malison RT; Baldwin RM; Seibyl JP; Innis RB
    Am J Psychiatry; 2002 Feb; 159(2):309-12. PubMed ID: 11823278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine transporter gene, response to methylphenidate and cerebral blood flow in attention-deficit/hyperactivity disorder: a pilot study.
    Rohde LA; Roman T; Szobot C; Cunha RD; Hutz MH; Biederman J
    Synapse; 2003 May; 48(2):87-9. PubMed ID: 12619042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin and the therapeutic effects of ritalin.
    Volkow ND; Gatley SJ; Fowler JS; Wang GJ; Swanson J
    Science; 2000 Apr; 288(5463):11. PubMed ID: 10766624
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography.
    Krause KH; Dresel SH; Krause J; Kung HF; Tatsch K
    Neurosci Lett; 2000 May; 285(2):107-10. PubMed ID: 10793238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder.
    Cheon KA; Ryu YH; Kim YK; Namkoong K; Kim CH; Lee JD
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):306-11. PubMed ID: 12552351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dopamine transporter and attention-deficit/hyperactivity disorder.
    Madras BK; Miller GM; Fischman AJ
    Biol Psychiatry; 2005 Jun; 57(11):1397-409. PubMed ID: 15950014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the dopamine transporter gene (DAT1) with poor methylphenidate response.
    Winsberg BG; Comings DE
    J Am Acad Child Adolesc Psychiatry; 1999 Dec; 38(12):1474-7. PubMed ID: 10596245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal dopamine transporter alterations in ADHD: pathophysiology or adaptation to psychostimulants? A meta-analysis.
    Fusar-Poli P; Rubia K; Rossi G; Sartori G; Balottin U
    Am J Psychiatry; 2012 Mar; 169(3):264-72. PubMed ID: 22294258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder.
    Krause KH; Dresel SH; Krause J; la Fougere C; Ackenheil M
    Neurosci Biobehav Rev; 2003 Nov; 27(7):605-13. PubMed ID: 14624805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Model" behavior.
    Sarkis EH
    Science; 2000 Mar; 287(5461):2160-2. PubMed ID: 10744536
    [No Abstract]   [Full Text] [Related]  

  • 18. Attention deficit and hyperactivity disorder: review of genetic association studies.
    Galili-Weisstub E; Segman RH
    Isr J Psychiatry Relat Sci; 2003; 40(1):57-66. PubMed ID: 12817670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How stimulant drugs may calm hyperactivity.
    Marx J
    Science; 1999 Jan; 283(5400):306. PubMed ID: 9925481
    [No Abstract]   [Full Text] [Related]  

  • 20. Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder.
    Krause KH; Dresel SH; Krause J; Kung HF; Tatsch K; Ackenheil M
    Int J Neuropsychopharmacol; 2002 Jun; 5(2):111-3. PubMed ID: 12135534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.